Literature DB >> 30037697

Sequencing of the GBA coactivator, Saposin C, in Parkinson disease.

Bouchra Ouled Amar Bencheikh1, Etienne Leveille2, Jennifer A Ruskey3, Dan Spiegelman4, Christopher Liong5, Edward A Fon6, Guy A Rouleau7, Yves Dauvilliers8, Nicolas Dupre9, Roy N Alcalay10, Ziv Gan-Or11.   

Abstract

Saposin C (SapC), encoded by PSAP, is required for the activity of glucocerebrosidase, encoded by GBA. Although GBA mutations have been studied thoroughly in Parkinson disease (PD), genetic studies on SapC are still lacking. PSAP was sequenced in 1123 PD patients and 1153 controls, and data from additional 1167 patients and 1685 controls were examined. A total of 6 patients had SapC mutations in the 2 combined cohorts, but no statistically significant association after correction for multiple comparisons was found. Larger studies are necessary to examine the role of very rare SapC variants in PD.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  GBA; Genetics; Parkinson's disease; Saposin C

Mesh:

Substances:

Year:  2018        PMID: 30037697      PMCID: PMC6215722          DOI: 10.1016/j.neurobiolaging.2018.06.034

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  19 in total

1.  Saposin C mutations in Gaucher disease patients resulting in lysosomal lipid accumulation, saposin C deficiency, but normal prosaposin processing and sorting.

Authors:  Anna M Vaccaro; Marialetizia Motta; Massimo Tatti; Susanna Scarpa; Laura Masuelli; Meenakshi Bhat; Marie T Vanier; Anna Tylki-Szymanska; Rosa Salvioli
Journal:  Hum Mol Genet       Date:  2010-05-19       Impact factor: 6.150

2.  Gaucher disease due to saposin C deficiency is an inherited lysosomal disease caused by rapidly degraded mutant proteins.

Authors:  Marialetizia Motta; Serena Camerini; Massimo Tatti; Marialuisa Casella; Paola Torreri; Marco Crescenzi; Marco Tartaglia; Rosa Salvioli
Journal:  Hum Mol Genet       Date:  2014-06-12       Impact factor: 6.150

3.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

4.  Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations.

Authors:  Roy N Alcalay; Oren A Levy; Cheryl C Waters; Stanley Fahn; Blair Ford; Sheng-Han Kuo; Pietro Mazzoni; Michael W Pauciulo; William C Nichols; Ziv Gan-Or; Guy A Rouleau; Wendy K Chung; Pavlina Wolf; Petra Oliva; Joan Keutzer; Karen Marder; Xiaokui Zhang
Journal:  Brain       Date:  2015-06-27       Impact factor: 13.501

5.  Differential effects of severe vs mild GBA mutations on Parkinson disease.

Authors:  Ziv Gan-Or; Idan Amshalom; Laura L Kilarski; Anat Bar-Shira; Mali Gana-Weisz; Anat Mirelman; Karen Marder; Susan Bressman; Nir Giladi; Avi Orr-Urtreger
Journal:  Neurology       Date:  2015-02-04       Impact factor: 9.910

6.  Mutational analysis in a patient with a variant form of Gaucher disease caused by SAP-2 deficiency.

Authors:  M A Rafi; G de Gala; X L Zhang; D A Wenger
Journal:  Somat Cell Mol Genet       Date:  1993-01

7.  Non-neuronopathic Gaucher disease due to saposin C deficiency.

Authors:  A Tylki-Szymańska; B Czartoryska; M-T Vanier; B J M H Poorthuis; J A E Groener; A Ługowska; G Millat; A M Vaccaro; E Jurkiewicz
Journal:  Clin Genet       Date:  2007-10-07       Impact factor: 4.438

Review 8.  Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA).

Authors:  Kathleen S Hruska; Mary E LaMarca; C Ronald Scott; Ellen Sidransky
Journal:  Hum Mutat       Date:  2008-05       Impact factor: 4.878

9.  A Guided Tour of the Structural Biology of Gaucher Disease: Acid-β-Glucosidase and Saposin C.

Authors:  Raquel L Lieberman
Journal:  Enzyme Res       Date:  2011-11-22

10.  Genic intolerance to functional variation and the interpretation of personal genomes.

Authors:  Slavé Petrovski; Quanli Wang; Erin L Heinzen; Andrew S Allen; David B Goldstein
Journal:  PLoS Genet       Date:  2013-08-22       Impact factor: 5.917

View more
  6 in total

1.  Lack of evidence for genetic association of saposins A, B, C and D with Parkinson's disease.

Authors:  Yuri Ludwig Sosero; Sara Bandres-Ciga; Sharon Hassin-Baer; Roy N Alcalay; Ziv Gan-Or
Journal:  Brain       Date:  2020-09-01       Impact factor: 13.501

2.  LRRK2 p.M1646T is associated with glucocerebrosidase activity and with Parkinson's disease.

Authors:  Yuri L Sosero; Eric Yu; Lynne Krohn; Uladzislau Rudakou; Kheireddin Mufti; Jennifer A Ruskey; Farnaz Asayesh; Sandra B Laurent; Dan Spiegelman; Stanley Fahn; Cheryl Waters; S Pablo Sardi; Sara Bandres-Ciga; Roy N Alcalay; Ziv Gan-Or; Konstantin Senkevich
Journal:  Neurobiol Aging       Date:  2021-02-28       Impact factor: 5.133

3.  Recombinant pro-CTSD (cathepsin D) enhances SNCA/α-Synuclein degradation in α-Synucleinopathy models.

Authors:  Susy Prieto Huarcaya; Alice Drobny; André R A Marques; Alessandro Di Spiezio; Jan Philipp Dobert; Denise Balta; Christian Werner; Tania Rizo; Lisa Gallwitz; Simon Bub; Iva Stojkovska; Nandkishore R Belur; Jens Fogh; Joseph R Mazzulli; Wei Xiang; Amitkumar Fulzele; Mario Dejung; Markus Sauer; Beate Winner; Stefan Rose-John; Philipp Arnold; Paul Saftig; Friederike Zunke
Journal:  Autophagy       Date:  2022-04-28       Impact factor: 13.391

Review 4.  GBA, Gaucher Disease, and Parkinson's Disease: From Genetic to Clinic to New Therapeutic Approaches.

Authors:  Giulietta M Riboldi; Alessio B Di Fonzo
Journal:  Cells       Date:  2019-04-19       Impact factor: 6.600

5.  Putative second hit rare genetic variants in families with seemingly GBA-associated Parkinson's disease.

Authors:  Muhammad Aslam; Nirosiya Kandasamy; Anwar Ullah; Nagarajan Paramasivam; Mehmet Ali Öztürk; Saima Naureen; Abida Arshad; Mazhar Badshah; Kafaitullah Khan; Muhammad Wajid; Rashda Abbasi; Muhammad Ilyas; Roland Eils; Matthias Schlesner; Rebecca C Wade; Nafees Ahmad; Jakob von Engelhardt
Journal:  NPJ Genom Med       Date:  2021-01-05       Impact factor: 8.617

Review 6.  Clinical Sphingolipids Pathway in Parkinson's Disease: From GCase to Integrated-Biomarker Discovery.

Authors:  Ali Esfandiary; David Isaac Finkelstein; Nicolas Hans Voelcker; David Rudd
Journal:  Cells       Date:  2022-04-15       Impact factor: 7.666

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.